Valuation: M3, Inc.

Market Cap 1,226B 7.67B 6.92B 6.39B 5.78B 10.93B 720B 11.2B 76.57B 30.52B 385B 28.79B 28.18B P/E 2027 *
23.9x
P/E 2028 * 21.5x
Enterprise Value 1,108B 6.93B 6.24B 5.77B 5.22B 9.87B 650B 10.11B 69.14B 27.56B 348B 26B 25.45B EV / Sales 2027 *
2.86x
EV / Sales 2028 * 2.53x
Free-Float
61.47%
Yield 2027 *
1.25%
Yield 2028 * 1.37%
1 day-1.37%
1 week+10.56%
Current month-0.69%
1 month-1.20%
3 months+13.61%
6 months+36.17%
Current year-13.51%
1 week 5.65
Extreme 5.6501
6.14
1 month 4.88
Extreme 4.88
6.4
Current year 3.97
Extreme 3.97
7.08
1 year 3.97
Extreme 3.97
8.85
3 years 3.79
Extreme 3.79
8.85
5 years 3.79
Extreme 3.79
29.91
10 years 3.79
Extreme 3.79
52.42
Manager TitleAgeSince
President 61 2000-09-28
Investor Relations Contact 46 -
Corporate Officer/Principal - -
Director TitleAgeSince
Director/Board Member 61 2000-09-28
Director/Board Member 54 2012-05-31
Director/Board Member 61 2016-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.37%+10.56% - - 7.67B
+2.11%+1.56%+0.73%+121.32% 3,592B
-1.97%-0.20%+0.27%+91.25% 1,607B
+0.29%-1.78%+18.34%+67.54% 576B
-2.25%-6.92%-39.03%+29.31% 470B
+2.02%-2.79%-43.21%+44.31% 265B
-1.17%-3.58%-36.87%+22.68% 252B
+1.81%-2.46%-6.09%+143.33% 192B
+0.90%+1.16%-24.49%+37.03% 144B
+0.48%-2.95%-4.76%+256.25% 125B
Average -0.16%-0.61%-15.01%+90.34% 803B
Weighted average by Cap. -0.04%+0.68%-4.26%+99.33%

Financials

2027 *2028 *
Net sales 387B 2.42B 2.18B 2.02B 1.82B 3.45B 227B 3.53B 24.16B 9.63B 122B 9.09B 8.89B 422B 2.64B 2.38B 2.2B 1.99B 3.76B 247B 3.85B 26.32B 10.49B 132B 9.9B 9.69B
Net income 51.02B 319M 288M 266M 240M 455M 29.94B 466M 3.19B 1.27B 16.03B 1.2B 1.17B 56.48B 353M 318M 294M 266M 503M 33.14B 516M 3.53B 1.41B 17.75B 1.33B 1.3B
Net Debt -119B -744M -670M -619M -560M -1.06B -69.76B -1.09B -7.42B -2.96B -37.36B -2.79B -2.73B -161B -1B -905M -836M -756M -1.43B -94.19B -1.47B -10.02B -3.99B -50.44B -3.77B -3.69B
Projected Income Statement - Annual - M3, Inc.
Logo M3, Inc.
M3 Inc is a Japan-based company mainly engaged in the provision of services centering on the platform of healthcare. The Company has five business segments. Medical Platforms segment conducts marketing-related businesses in Japan utilizing the Internet and real operations centered on medical employee specialized site m3.com. Evidence Solution segment is engaged in the contract research organization (CRO) business that supports clinical development work and research, and site management organization (SMO) business that manages the clinical trial operations. Career Solutions segment is engaged in human resource services for healthcare professionals. Site Solution segment provides operational support for medical institutions and home-visit nursing services. Overseas segment provides services of medical related marketing support, research and careers, utilizing the medical employee specialized sites in the United States, the United Kingdom, China, Korea, India, France, Germany and Spain.
Employees
17,010
Date Price Change Volume
26-11-11 US$5.760 -1.37% 294,226
26-11-10 US$5.840 -2.34% 298,454
26-11-09 US$5.980 +5.10% 79,742
26-11-06 US$5.690 -3.40% 68,325
26-11-05 US$5.890 +13.05% 282,224
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - M3, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
1,843.00JPY
Average target price
1,944.17JPY
Spread / Average Target
+5.49%